Loading…
Japanese cosmetics maker selling skincare and makeup under brands including KOSE, Sekkisei and Amino Mason.
Japanese cosmetics maker selling skincare and makeup under brands including KOSE, Sekkisei and Amino Mason.
Sells through department stores, drugstores, specialty beauty shops, travel retail and online. Premium lines such as Sekkisei are its main route to Chinese shoppers, whether they buy in Japan or in mainland China, while drugstore lines add everyday volume.
In one line: Japan's Estee Lauder.
Moat: narrow (brand, distribution). Established cosmetics brand portfolio and department-store/travel-retail distribution in Asia.
Headquarters: Tokyo, Japan · Founded: 1946 · Employees: 8,566
Size KOSE (4922.T) is a Japan Consumer Staples company (Household/Personal Care) with a market value of $2.16B, the 458th largest of 1,379 Japan companies the cockpit tracks. Shares closed at ¥5,971 on 6 Nov 2026.
Performance Over six months the shares gained 7.1%, against -5.7% for the median peer and +1.8% for the Japan market (cap-weighted) — 8th highest of 21 in its peer set.
Growth Revenue grew 3.2% over the last twelve months (peer median +3.5%); the operating margin is 4.1% (peer median 10.4%).
Valuation It trades at 27.2× forward earnings against a peer median of 20.2× (6th most expensive of 21).
Capital Return on invested capital runs 1.3 points below its cost of capital (5.0% WACC).
Next results Next results expected around 10 Nov 2026 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ¥335B | ¥330B | ¥323B | ¥300B | ¥289B |
| Revenue growth | — | +2% | +7% | +4% | — |
| Gross profit | ¥225B | ¥222B | ¥217B | ¥206B | ¥201B |
| EBITDA | ¥26.0B | ¥31.0B | ¥28.4B | ¥26.9B | ¥33.3B |
| Net income | ¥13.7B | ¥15.1B | ¥7.51B | ¥11.7B | ¥18.8B |
| Free cash flow | n/a | -¥5.92B | -¥382M | ¥27.1B | ¥16.0B |
| Capital expenditure | n/a | ¥21.5B | ¥21.0B | ¥5.53B | ¥7.10B |
| Total debt | ¥10.8B | ¥10.7B | ¥11.2B | ¥10.2B | ¥9.98B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| KOSE 4922.T | $2.16B | +7% | +3% | 4% | 27.2× | n/a |
| Shiseido 4911.T | $9.52B | +20% | +5% | 4% | 32.8× | 17.5% |
| Pola Orbis 4927.T | $1.96B | +8% | +1% | 10% | 28.8× | -3.1% |
| Estée Lauder Companies (The) EL | $39.9B | +28% | +6% | 13% | 31.1× | 16.8% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 4922.T | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +11.8% | +2.4% | 2nd highest of 21 |
| 6-month return | +7.1% | -5.7% | 8th highest of 21 |
| Distance from 52-week high | -8.1% | -29.5% | 6th highest of 21 |
| Revenue growth (TTM) | +3.2% | +3.5% | 11th highest of 21 |
| Operating margin | 4.1% | 10.4% | 5th lowest of 21 |
| Forward P/E | 27.2× | 20.2× | 6th most expensive of 21 |
| ROIC minus cost of capital | -1.3 pp | +6.5 pp | 4th lowest of 21 |
| EV / EBITDA | 11.3× | 12.3× | 6th cheapest of 12 |
| Net debt / EBITDA | -2.5× | -0.6× | 4th least indebted of 13 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| KOSE 4922.T | Japan | $2.16B | +7% | +3% | 4% | 27.2× | n/a | n/a |
| Cosmax 192820.KS | South Korea | $2.13B | +21% | +16% | 8% | 16.6× | n/a | n/a |
| Softcare 2698.HK | Hong Kong | $2.20B | -5% | +25% | 25% | 14.4× | 8.7% | +20.9% |
| Pola Orbis 4927.T | Japan | $1.96B | +8% | +1% | 10% | 28.8× | -3.1% | -0.7% |
| Procter & Gamble Hygiene & Health Care PGHH.NS | India | $2.40B | -29% | -2% | 24% | 27.3× | 15.4% | +7.4% |
| Kolmar Korea 161890.KS | South Korea | $1.89B | +23% | +13% | 10% | 13.0× | -0.9% | +15.5% |
| Blue Moon 6993.HK | Hong Kong | $1.88B | -15% | -2% | -2% | 93.6× | n/a | n/a |
| Yunnan Botanee Bio-Technology 300957.SZ | China | $1.84B | -28% | +7% | 9% | 21.2× | 4.5% | +15.3% |
| LG H&h 051900.KS | South Korea | $2.56B | -8% | -3% | 3% | 18.5× | -0.1% | -4.1% |
| Gillette India GILLETTE.NS | India | $2.56B | -7% | +8% | 28% | 33.0× | 16.0% | +13.0% |
| Emami EMAMILTD.NS | India | $1.80B | -15% | +3% | 20% | 21.4× | 21.7% | +5.6% |
| Shanghai Jahwa United 600315.SS | China | $1.74B | -13% | +9% | 2% | 18.1× | 17.1% | -2.1% |
| Winner Medical 300888.SZ | China | $2.69B | -2% | +4% | 11% | 20.9× | -4.3% | -2.6% |
| Giant Biogene 2367.HK | Hong Kong | $2.76B | -34% | -10% | 32% | 9.7× | -8.0% | +34.9% |
| Pigeon 7956.T | Japan | $1.66B | +30% | +7% | 13% | 26.3× | -1.3% | +1.9% |
| Energizer ENR | United States | $1.63B | +26% | +2% | 16% | 7.2× | -5.2% | +1.5% |
| Harbin Fuerjia Technology 301371.SZ | China | $1.58B | -30% | +28% | 20% | 22.5× | 8.7% | +3.6% |
| Proya Cosmetics 603605.SS | China | $2.97B | -19% | +2% | 13% | 11.1× | -4.8% | +23.1% |
| AMOREPACIFIC 002790.KS | South Korea | $1.55B | -3% | +9% | 9% | 8.4× | -17.9% | -1.3% |
| Intercos ICOS.MI | Italy | $1.50B | +16% | -5% | 9% | 19.5× | 4.5% | +11.5% |
| Chongqing Baiya Sanitary Products 003006.SZ | China | $1.49B | +25% | 0% | 3% | 41.2× | 30.6% | +22.8% |